C. Koski

发表

Sublytic C5b‐9‐stimulated Schwann cell survival through PI 3‐kinase‐mediated phosphorylation of BAD

L. Soane, S. Hila, C. Koski, 2001, Glia.

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society *

J. Pollard, C. Sommer, P. Bouche, 2006, European journal of neurology.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

Belgium, Canada., Australia., 2010, Journal of the peripheral nervous system : JPNS.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

P. Bergh, J. M., J. Pollard, 2010, Journal of the peripheral nervous system : JPNS.

Guillain-Barré syndrome.

R. F. Mayer, R. Khurana, C. Koski, 1984, American family physician.

EFNS/PNS CIDP GUIDELINES European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - F

P. Bergh, J. Pollard, C. Koski, 2010 .

European Federation of Neurological Societies / Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy : Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision Members

P. Bergh, J. Pollard, C. Sommer, 2010 .

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

M. Shin, C. Koski, P. Vanguri, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.

K. Joiner, M. Shin, C. Koski, 1986, Journal of immunology.

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy *

R. Hughes, J. Pollard, C. Sommer, 2006, European journal of neurology.

Autonomic dysfunction in Lambert-Eaton myasthenic syndrome

R. F. Mayer, R. Khurana, C. Koski, 1988, Journal of the Neurological Sciences.

Activation of the alternative pathway of complement by human peripheral nerve myelin.

M. Shin, C. Koski, P. Vanguri, 1985, Journal of immunology.

Paraproteinaemic Demyelinating Neuropathies

P. Bergh, J. Pollard, C. Sommer, 2010 .

Sublytic Terminal Complement Complexes Decrease POGene Expression in Schwann Cells

C. Koski, S. Dashiell, 1999, Journal of neurochemistry.

Clinical correlation with anti‐peripheral‐nerve myelin antibodies in Guillain‐Barré syndrome

R. F. Mayer, C. Koski, E. Gratz, 1986, Annals of neurology.

Use of intravenous gamma globulins in neuroimmunologic diseases.

C. Koski, J. Howard, N. Latov, 2001, The Journal of allergy and clinical immunology.

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

M. Shin, C. Koski, R. Humphrey, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Adherence-mediated T cell activation in multiple sclerosis and other neurological disorders

C. Koski, G. Lewis, R. Kamin-Lewis, 1994, Journal of Neuroimmunology.

Mechanisms of Schwann cell damage in inflammatory neuropathy.

C. Koski, 1997, The Journal of infectious diseases.

Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis.

C. Koski, M. Pappolla, F. Vriesendorp, 1997, The International journal of neuroscience.

Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate.

M. Shin, C. Koski, M. Mayer, 1983, Journal of immunology.

Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in schwann cells

C. Koski, P. Vanguri, S. Dashiell, 1997, Glia.

Complement depletion affects demyelination and inflammation in experimental allergic neuritis

C. Koski, M. Pappolla, F. Vriesendorp, 1995, Journal of Neuroimmunology.

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

K. Joiner, M. Shin, C. Koski, 1987, The Journal of clinical investigation.

Treatment of Multifocal Motor Neuropathy with Intravenous Immunoglobulin

C. Koski, 2014, Journal of Clinical Immunology.

A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy

C. Koski, A. Hahn, V. Lawson, 2013, Journal of the peripheral nervous system : JPNS.

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

L. Magder, R. Barohn, C. Koski, 2009, Journal of the Neurological Sciences.

Response to comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy

R. Hughes, J. Pollard, C. Sommer, 2006 .

European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

R. Hughes, P. Bergh, J. Pollard, 2005, Journal of the peripheral nervous system : JPNS.

Therapy of CIDP and related immune-mediated neuropathies

C. Koski, 2002, Neurology.

Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis

M. Blaser, C. Koski, F. Vriesendorp, 1993, Annals of neurology.

Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome

M. Blaser, C. Koski, B. Mishu, 1993, Annals of Internal Medicine.

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

J. Pollard, C. Sommer, P. Bouche, 2006, European journal of neurology.

Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice

G. Parry, R. Lewis, R. Hughes, 2010, Journal of the peripheral nervous system : JPNS.

Electrophysiological studies in Guillain-Barré syndrome:correlation with antibodies to GM1, GDIB andCampylobacter jejuni

R. F. Mayer, W. Triggs, C. Koski, 1995, Journal of Neurology.

Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.

R. F. Mayer, C. Koski, F. Vriesendorp, 1991, Archives of neurology.

Intravenous Immunoglobulin Use for Neurologic Diseases

C. Koski, Jardiolyn Valino Patterson, 2006, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Initial and Long-Term Management of Autoimmune Neuropathies

C. Koski, 2005, CNS drugs.

Subarachnoid hemorrhage in a patient with lyme disease

C. Koski, M. Zagardo, M. Chehrenama, 1997, Neurology.

Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype

C. Koski, S. Sawant-Mane, Alden E. Estep, 1994, Journal of Neuroimmunology.

Electrophysiologic studies in the Guillain–Barré syndrome: Effects of plasma exchange and antibody rebound

R. F. Mayer, C. Koski, S. Rudnicki, 1992, Muscle & nerve.

Guillain-Barré syndrome and parenteral gangliosides

C. Koski, N. Latov, P. Walicke, 1991, The Lancet.

In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexes

C. Koski, S. Sawant-Mane, M. Clark, 1991, Annals of neurology.

Characterization of complement‐fixing antibodies to peripheral nerve myelin in Guillain‐Barré syndrome

C. Koski, 1990, Annals of neurology.

Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.

C. Koski, F. Jungalwala, D. K. Chou, 1989, The Journal of clinical investigation.

Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy

R. F. Mayer, C. Koski, M. Chehrenama, 1998, Neurology.

Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.

M. Shin, C. Koski, D. F. Carney, 1985, Journal of immunology.

Chronic Inflammatory Demyelinating Polyradiculoneuropathy 101—Pitfalls and Pearls of Diagnosis and Treatment

C. Koski, T. Brannagan, S. Beydoun, 2017 .

Anti-peripheral nerve myelin antibodies and terminal activation products of complement in serum of patients with acute brachial plexus neuropathy.

C. Koski, F. Vriesendorp, G. Dmytrenko, 1993, Archives of neurology.

JNK1 activation mediates C5b‐9‐induced P0 mRNA instability and P0 gene expression in Schwann cells

H. Rus, S. Hila, C. Koski, 2006, Journal of the peripheral nervous system : JPNS.

CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells

V. Holers, C. Koski, B. Morgan, 1996, Journal of Neuroimmunology.

Oxidative metabolism of skeletal muscle in steroid atrophy.

C. Koski, S. R. Max, D. Rifenberick, 1974, Archives of neurology.

Glycolysis in skeletal muscle regeneration

C. Koski, K. Wagner, S. R. Max, 1976, Experimental Neurology.

Complement activation in acquired and hereditary amyloid neuropathy

P. Dyck, C. Hafer-Macko, C. Koski, 2000, Journal of the peripheral nervous system : JPNS.

Metabolic studies of skeletal muscle regeneration.

C. Koski, S. R. Max, D. Rifenberick, 1974, Experimental neurology.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision

J. Pollard, C. Sommer, P. Bouche, 2010, European journal of neurology.

Regulation of cytokine-induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinase-mediated proapoptotic signaling.

S. Hila, C. Koski, G. Hoffman, 2004, Endocrinology.

Divergent Effects of Ovarian Steroids on Neuronal Survival during Experimental Allergic Encephalitis in Lewis Rats

C. Koski, W. Le, G. Hoffman, 2001, Experimental Neurology.

Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.

M. Shin, C. Koski, M. Mayer, 1983, Proceedings of the National Academy of Sciences of the United States of America.

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

L. Magder, P. Stolley, G. Terracciano, 1998, The New England journal of medicine.

Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: Pathogenesis and Treatment

C. Koski, 1994, Seminars in neurology.

Normality of erythrocyte phospholipids in Duchenne muscular dystrophy.

C. Koski, E. Kolodny, F. Jungalwala, 1978, Clinica chimica acta; international journal of clinical chemistry.

Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis

H. Rus, C. Koski, S. Dashiell, 2000, Glia.

Complement Regulatory Molecules on Human Myelin and Glial Cells: Differential Expression Affects the Deposition of Activated Complement Proteins

M. Shin, C. Koski, G. Hansch, 1996, Journal of neurochemistry.

Substrate utilization by the denervated rat hemidiaphragm.

C. Koski, S. R. Max, 1974, Experimental neurology.

Systemic Recombinant α-2Interferon Therapy in Relapsing Multiple Sclerosis

R. Hirsch, H. Panitch, C. Koski, 1986 .

Immunoglobulin use in management of inflammatory neuropathy

C. Koski, 2009 .

Incorporation of P0 Protein into Liposomes: Demonstration of a Two‐Domain Structure by Immunochemical and PAGE Analysis

C. Koski, C. Hudson, M. Franko, 1984, Journal of neurochemistry.

Comparison of the Protein Composition of Myelin of Motor and Sensory Nerves

C. Koski, S. R. Max, 1980, Journal of neurochemistry.

The natural history of hereditary neuralgic amyotrophy in the Dutch population.

B. Engelen, J. Meuleman, B. Falck, 2000 .

Complement‐Fixing Antiperipheral Myelin Antibodies and C9 Neoantigen in Serum of Patients with Guillain‐Barré Syndrome: Quantitation, Kinetics, and Clinical Correlation

C. Koski, 1987, Annals of the New York Academy of Sciences.

Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.

C. Koski, Martin E. Sanders, Elaine Alexander, 1987, Journal of immunology.

J. Pollard, C. Sommer, P. Bouche, 2006, European journal of neurology.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision

J. Pollard, C. Sommer, C. Koski, 2010, Journal of the peripheral nervous system : JPNS.

Chronic Inflammatory Demyelinating Polyneuritis

C. Koski, 2006 .